Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Torben Ostergaard, listed as an officer (CEO Spinnaker) of Hippo Holdings Inc. (HIPO), reported a sale of common stock on 09/10/2025. The Form 4 shows 1,358 shares disposed at a price of $36.97 per share, reducing his direct holdings to 60,975 shares after the transaction. The filing notes those holdings include 52,671 RSUs, and the form was signed on behalf of Mr. Ostergaard by an attorney-in-fact, Guy Zeltser, on 09/11/2025.
The report is a standard Section 16 disclosure of an insider sale and provides explicit details on the number of shares sold, sale price, and resulting beneficial ownership. No derivative transactions or additional material terms are reported in this filing.
Guy Zeltser, reported as Chief Financial Officer of Hippo Holdings Inc. (HIPO), filed a Form 4 disclosing an insider sale on 09/10/2025. The filing shows a disposition of 1,029 shares of Hippo common stock at a price of $36.97 per share (transaction code F). After the sale, the reporting person beneficially owned 80,038 shares in total; the filing specifies that this total includes 65,817 RSUs. The Form 4 was filed by one reporting person and is signed by Guy Zeltser on 09/11/2025.
Richard McCathron, who serves as Chief Executive Officer and a director of Hippo Holdings Inc. (HIPO), reported a sale of 1,358 shares of the company's common stock on 09/10/2025 at a price of $36.97 per share on a Form 4 filing. After the reported sale, his total beneficial ownership is 469,030 shares, which the filing states includes 209,014 restricted stock units (RSUs).
The filing is a routine Section 16 disclosure of an insider disposition and indicates the sale was executed through a reporting process. The report was submitted by an attorney-in-fact on behalf of Mr. McCathron and contains no additional comments about intent, planned future transactions, or derivative positions.
Insider sale by Hippo Holdings CEO and Director. Richard McCathron reported a sale of 2,725 shares of Hippo Holdings Inc. (HIPO) on 09/08/2025 under a Rule 10b5-1 trading plan adopted December 3, 2024. The weighted average sale price was $34.1172, reflecting execution at prices between $34.00 and $34.26. After the sale, the reporting person beneficially owned 470,388 shares, which include 212,464 RSUs. The Form 4 was executed on 09/10/2025 by an attorney-in-fact and discloses the reporting person’s undertaking to provide detailed trade-by-trade pricing upon request.
Richard McCathron, Chief Executive Officer and director of Hippo Holdings Inc. (HIPO), reported an insider sale. On 08/22/2025 he disposed of 2,275 shares of Hippo common stock at a price of $34.0004 per share. After the transaction he beneficially owned 473,113 shares in total, which includes 212,464 restricted stock units (RSUs). The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2024, indicating pre-established instructions governed the trades. The Form 4 was signed on behalf of Mr. McCathron by an attorney-in-fact on 08/26/2025.
Thomas B. Akin and related entities reported collective beneficial ownership of 2,405,304 shares of Hippo Holdings Inc. (HIPO), representing 9.61% of the outstanding common stock. The filing breaks ownership down by holder: Thomas B. Akin directly owns 1,221,832 shares (4.9% of the class), Talkot Fund, LP owns 941,060 shares (3.8%), Talkot Partners V, LP owns 7,412 shares (0.0%), Akin Family Foundation owns 125,000 shares (0.5%), Karen Hochster owns 60,000 shares (0.2%), and Kyle Akin owns 50,000 shares (0.2%). The 9.61% figure is calculated using 25,028,054 shares outstanding as of June 30, 2025 per Hippo’s Form 10-Q. The filing states the securities were not acquired to change or influence control and indicates shared voting and dispositive power over the 2,405,304 shares.
Hippo Holdings Inc. (HIPO) filed a Form 144 to report a proposed sale of securities. The notice states that 5,000 common shares will be sold through Morgan Stanley Smith Barney LLC on or about 08/22/2025, with an aggregate market value of $164,800.00. The filing reports 25,028,054 shares outstanding for the class.
The shares were acquired as Restricted Stock Units from the issuer on 12/24/2020 and payment was recorded on the same date. The filer represents they are not aware of undisclosed material adverse information and indicates no securities were sold in the past three months.
Michael Stienstra, General Manager & Chief Insurance Officer of Hippo Holdings Inc. (HIPO), reported a sale of 2,341 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 78,396 shares, which the filer notes includes 46,271 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction code F indicating a sale, and provides the post-transaction beneficial ownership figure but no additional context about purpose of sale or planned transactions.
Torben Ostergaard, reporting person and officer at Hippo Holdings Inc. (HIPO), reported a sale of 2,016 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 62,333 shares, which the filing notes include 56,121 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing provides only the single non-derivative sale and the post-transaction beneficial ownership amount.
Hippo Holdings Inc. insider transaction: Chief Financial Officer and director Guy Zeltser reported a sale of 3,973 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 81,067 shares, which the filing states includes 67,842 RSUs. The Form 4 is signed by Guy Zeltser on 08/18/2025. The filing identifies his role as Chief Financial Officer and Director and is reported under Section 16.